As of the latest SEC filings, Autolus Therapeutics plc (AUTL) is held by 11 institutional funds. The largest fund shareholder is iShares Biotechnology ETF (IBB), holding an estimated $1,823,919.78 in market value, representing 0.02% of its portfolio.
Funds holding Autolus Therapeutics plc (AUTL)
Source: SEC Form N-PORT institutional portfolio disclosures
- Ticker:
- AUTL
- CIK:
- 0001730463
| Fund | Type | Manager | Weight | Market Value | Shares |
Report Date
|
Filing Date
|
|---|---|---|---|---|---|---|---|
|
IBB
iShares Biotechnology ETF
|
ETF | BlackRock / iShares | 0.02% | $1,823,919.78 | 1,321,681 | Mar 31, 2026 | May 28, 2026 |
|
SHSKX
BlackRock Health Sciences Opportunities Portfolio
|
MF | BlackRock / iShares | 0.02% | $1,246,533.57 | 728,967 | Feb 27, 2026 | Apr 24, 2026 |
|
FNCMX
Fidelity Nasdaq Composite Index Fund
|
MF | Fidelity | 0.00% | $189,088.38 | 110,578 | Feb 28, 2026 | Apr 24, 2026 |
|
BMEZ
BlackRock Health Sciences Term Trust
|
CEF | BlackRock / iShares | 0.02% | $187,645.50 | 135,975 | Mar 31, 2026 | May 28, 2026 |
|
GWX
State Street(R) SPDR(R) S&P(R) International Small Cap ETF
|
ETF | State Street (SPDR) | 0.01% | $115,285.20 | 83,540 | Mar 31, 2026 | May 28, 2026 |
|
QQQS
Invesco NASDAQ Future Gen 200 ETF
|
ETF | Invesco | 0.57% | $80,445.24 | 47,044 | Feb 28, 2026 | Apr 28, 2026 |
|
BME
BlackRock Health Sciences Trust
|
CEF | BlackRock / iShares | 0.01% | $32,595.60 | 23,620 | Mar 31, 2026 | May 28, 2026 |
|
-
Health Sciences Portfolio
|
ETF | Independent / Boutique | 0.01% | $23,007.36 | 16,672 | Mar 31, 2026 | May 27, 2026 |
|
IBBQ
Invesco Nasdaq Biotechnology ETF
|
ETF | Invesco | 0.03% | $19,182.78 | 11,218 | Feb 28, 2026 | Apr 28, 2026 |
|
BIB
ProShares Ultra Nasdaq Biotechnology
|
ETF | ProShares | 0.02% | $15,838.02 | 9,262 | Feb 28, 2026 | Apr 24, 2026 |
|
BXMYX
Blackstone Alternative Multi-Strategy Fund
|
MF | Independent / Boutique | 0.00% | -$19,044.00 | -13,800 | Mar 31, 2026 | May 27, 2026 |
Advertisement (320x50)